OGRD Alliance Expands Biotech Initiatives to Asia and MENA Regions
The OGRD Alliance, a biotechnology organization led by Chief Scientific Officer Dr. Ramón Gutiérrez Sandoval, is expanding its OncoVix Program and PLPC-DB phospholipoproteomic module from Dubai into Asia and the Middle East. The MOVE follows recent licensing frameworks and international exposure of the PLPC Platform, backed by FDA-aligned audits and UAE-based legal and banking partners.
The Dubai hub now serves as the financial and logistical center for the group's operations across Asia and the Middle East. Strategic manufacturing and licensing agreements have been formalized with brokers in Japan and Singapore, reinforcing the alliance's role as a bridge between American scientific innovation and global life-science investment.
The proprietary PLPC technology integrates four scientific and regulatory pillars, including PLPC-DB, a non-cellular immunobiological module validated under FDA-aligned documentation, and PLPC-NX, a GRAS-certified nutritional platform synchronized with circadian and metabolic functions.
